| EN

Market Access Workshop Empowers Members in Navigating the Pharmaceutical Landscape

We are thrilled to announce the success of the HKAPI Market Access Workshop held on the afternoon of November 27. With an exceptional turnout of nearly 200 participants, this workshop has become the largest in terms of attendance in recent years.
Mr. Carvin Man, Co-Sponsor of the Patient Journey Navigation Task Force, warmly welcoming HKAPI members to the highly attended market access workshop, the largest in recent years.
An impressive gathering of nearly 200 participants makes this workshop the largest in recent years in terms of attendance.
The workshop attracted members from various functions including commercial, market access, medical, and regulatory, representing a wide range of expertise and experience levels, from newcomers to senior management such as general managers. This diverse audience contributed to a dynamic and enriching learning environment.
The workshop covered a comprehensive range of topics, providing an overview and invaluable tips on the Hong Kong drug registration process, enlistment, tender and reimbursement systems. Additionally, there was an introduction to the application of big data in supporting market access strategies and insights into organizing patient support programs to enhance patient affordability.
Ms. Kammy Leung, Co-Lead of the Patient Journey Navigation Task Force, presents an insightful overview of the Hong Kong drug registration system and its correlation with drug enlistment.
Feedback from the participants has been overwhelmingly positive, with the majority expressing their satisfaction with the content and applicability of the workshop. The speakers were highly regarded for their extensive knowledge and expertise, making the sessions insightful and useful for all attendees.
Mr. King Chan, Task Force Member, guides participants through the procedures and key considerations for successful HA DAC drug enlistment.
Task Force members provide an introduction to the HA drug enlistment and reimbursement system, engaging with participants and addressing their questions during the interactive Q&A session.
At the HKAPI, we are committed to the development of our members and strive to provide valuable workshops throughout the year. In addition to the Market Access Workshop, we also organize workshops that focus on regulatory systems, ethics and compliance, primary healthcare, and explore opportunities in the Greater Bay Area.
Task Force members share insights on various types of Patient Support Programs, discussing their operational models and strategies to enhance program awareness among healthcare professionals.
Ms. Sui Wong, Co-Lead of the Task Force, provides a comprehensive briefing to members on the different types of HA tender and outlines effective strategies for tender bidding across various product categories.
As an association, our mission is to serve our members by providing important information about the local pharmaceutical market. We continually aim to improve the overall well-being of the people of Hong Kong by making recommendations on healthcare policies and fostering strong relationships among our member companies, the government, and the community.
We are privileged to have Dr. CL Cheung, Associate Professor in the Department of Pharmacology and Pharmacy at the University of Hong Kong, as he enlightens us on the practical application of big data and provides insightful examples within the enlistment field.
HKAPI members engage in the Q&A session, posing thoughtful and meaningful questions to further enrich the discussion.
We extend our heartfelt gratitude to all participants for their active engagement and valuable contributions, which made the HKAPI Market Access Workshop a resounding success. Stay tuned for more exciting workshops and events in the future.
Members of the Patient Journey Navigation Task Force (2022-2024).
Close Bitnami banner